Now, nivolumab -- in combination with chemotherapy -- is indicated for the first-line treatment of adults with unresectable ...

Esophageal cancer remains one of the world's deadliest cancers, ranking 7th in incidence and 6th in cancer-related deaths ...

Among individuals with achalasia, male sex, older age and prior esophageal Candida infection increased risk for esophageal ...

Adjuvant nivolumab offered sustained survival benefits in resected esophageal/GEJ cancer post chemoradiation, with PD-L1 ...

When it comes to the use of PD-1 inhibitors in stomach cancer, the FDA has put its money where its mouth is. | After ...

The findings are notable in part because therapies have already been approved to target C5aR1 in other diseases.

ESCC accounts for nearly 90% of esophageal cancers globally with a five ... "Patients with metastatic esophageal squamous cell carcinoma continue to experience poor outcomes despite currently ...

Malawi holds the highest reported global age-standardized rate for esophageal squamous cell carcinoma (ESCC) incidence and ...

Researchers are also investigating the PD-1 immune checkpoint inhibitor as treatment before surgical and radiation treatment.

“Advanced esophageal squamous cell carcinoma is a difficult-to-treat ... 4,5 B7-H3 is overexpressed in a wide range of cancer types, including ESCC, and its overexpression has been shown to ...